bioMérieux receives U.S. 510(k) clearance and CLIA-waiver for Anterior Nasal Swab specimens, an additional sample type for use with the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini

18 Aug 2025 18:01 CEST

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1353341_PR_bioMerieux_SPOTFIRE_RST_Panel_Mini_ANSSTA_FDA_Clearance_20250818.pdf